# Measurement of Patient Reported Outcomes in Renal Transplant Patients With and Without Gastrointestinal (GI) Symptoms (PROGIS)

> **NCT00150007** · PHASE4 · COMPLETED · sponsor: **Novartis Pharmaceuticals** · enrollment: 335 (—)

## Conditions studied

- Kidney Maintenance Transplant

## Interventions

- **DRUG:** Enteric-coated Mycophenolate sodium (EC-MPS)

## Key facts

- **NCT ID:** NCT00150007
- **Lead sponsor:** Novartis Pharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-06
- **Primary completion:** 2005-06
- **Final completion:** —
- **Target enrollment:** 335 (—)
- **Last updated:** 2017-09-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00150007

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00150007, "Measurement of Patient Reported Outcomes in Renal Transplant Patients With and Without Gastrointestinal (GI) Symptoms (PROGIS)". Retrieved via AI Analytics 2026-07-06 from https://api.ai-analytics.org/clinical/NCT00150007. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*